STAT3 and pancreatic neoplasm: However, aberrant or constitutively activated STAT3 has been observed in many different cancers, such as colorectal, lung, breast, prostate, liver, and pancreas cancers, and STAT3 activation associates with poor prognosis of these cancers [4,5,6,7,8,9].